J Korean Med Assoc.  2019 Oct;62(10):525-532. 10.5124/jkma.2019.62.10.525.

Updated guideline for clinical evaluation and management of endometriosis

• Lee JH
• Lee BS

• KMID: 2459928
• DOI: http://doi.org/10.5124/jkma.2019.62.10.525

Abstract

Endometriosis is a common disease in reproductive aged women, and it detrimentally affects patients' quality of life and fertility. Moreover, because of the complexity of the disease itself, proper effective management is difficult. Within this context, this review proposes the guidelines of the Korean Society of Endometriosis and other world leading societies for endometriosis with an emphasis on: diagnosis of endometriosis, treatment for endometriosis associated pain and infertility, management of asymptomatic women, endometriosis associated malignancy, and endometriosis in postmenopausal women. In recent years, the importance of medical treatment as opposed to surgical removal in the management of endometriosis is gaining popularity. Many guidelines recommend empirical treatment without diagnostic laparoscopy and long term use of medication. This is also closely connected to the social trend of late marriage age and childbirth age. Nevertheless, timely surgical interventions and assisted reproductive procedures are still crucial in the management of endometriosis. Because treatment goals differ in each patient's individual situation, possible treatment options may vary and individualized management is also important. Ultimately, a multimodal approach that is tailored to each individual's therapeutic purpose is of paramount importance in the treatment of endometriosis.

Keyword

Endometriosis; Pain; Infertility; Reproductive techniques

MeSH Terms

Diagnosis
Endometriosis*
Female
Fertility
Humans
Infertility
Laparoscopy
Marriage
Parturition
Quality of Life
Reproductive Techniques

Reference

1. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W. European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29:400–412.

2. Ballard KD, Seaman HE, de Vries CS, Wright JT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study: Part 1. BJOG. 2008; 115:1382–1391.

3. Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update. 2005; 11:595–606.

4. Hwang H, Chung YJ, Lee SR, Park HT, Song JY, Kim H, Lee DY, Lee EJ, Kim MR, Oh ST. Clinical evaluation and management of endometriosis: guideline for Korean patients from Korean Society of Endometriosis. Obstet Gynecol Sci. 2018; 61:553–564.

5. Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril. 2012; 98:591–598.

6. Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014; 101:927–935.

7. Johnson NP, Hummelshoj L. World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis. Hum Reprod. 2013; 28:1552–1568.

8. Lemaire GS. More than just menstrual cramps: symptoms and uncertainty among women with endometriosis. J Obstet Gynecol Neonatal Nurs. 2004; 33:71–79.

9. Hirsch M, Begum MR, Paniz E, Barker C, Davis CJ, Duffy J. Diagnosis and management of endometriosis: a systematic review of international and national guidelines. BJOG. 2018; 125:556–564.

10. Hudelist G, English J, Thomas AE, Tinelli A, Singer CF, Keckstein J. Diagnostic accuracy of transvaginal ultrasound for non-invasive diagnosis of bowel endometriosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2011; 37:257–263.

11. Soares SR, Martínez-Varea A, Hidalgo-Mora JJ, Pellicer A. Pharmacologic therapies in endometriosis: a systematic review. Fertil Steril. 2012; 98:529–555.

12. Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol. 2011; 118:691–705.

13. Moghissi KS, Schlaff WD, Olive DL, Skinner MA, Yin H. Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis. Fertil Steril. 1998; 69:1056–1062.

14. Makarainen L, Rönnberg L, Kauppila A. Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis. Fertil Steril. 1996; 65:29–34.

15. Hart RJ, Hickey M, Maouris P, Buckett W. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2008; (2):CD004992.

16. Carmona F, Martinez-Zamora MA, Rabanal A, Martinez-Roman S, Balasch J. Ovarian cystectomy versus laser vaporization in the treatment of ovarian endometriomas: a randomized clinical trial with a five-year follow-up. Fertil Steril. 2011; 96:251–254.

17. Wright J, Lotfallah H, Jones K, Lovell D. A randomized trial of excision versus ablation for mild endometriosis. Fertil Steril. 2005; 83:1830–1836.

18. Proctor ML, Latthe PM, Farquhar CM, Khan KS, Johnson NP. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2005; (4):CD001896.

19. Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev. 2004; (3):CD003678.

20. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol. 2004; 160:784–796.

21. Hughes E, Brown J, Collins JJ, Farquhar C, Fedorkow DM, Vandekerckhove P. Ovulation suppression for endometriosis. Cochrane Database Syst Rev. 2007; (3):CD000155.

22. Marcoux S, Maheux R, Bérubé S. Canadian Collaborative Group on Endometriosis. Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med. 1997; 337:217–222.

23. Schenken RS. Modern concepts of endometriosis. Classification and its consequences for therapy. J Reprod Med. 1998; 43:3 Suppl. 269–275.

24. Vercellini P, Fedele L, Aimi G, De Giorgi O, Consonni D, Crosignani PG. Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system. Hum Reprod. 2006; 21:2679–2685.

25. Tummon IS, Asher LJ, Martin JS, Tulandi T. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril. 1997; 68:8–12.

26. Werbrouck E, Spiessens C, Meuleman C, D'Hooghe T. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril. 2006; 86:566–571.

27. Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006; (1):CD004635.

28. Opoien HK, Fedorcsak P, Byholm T, Tanbo T. Complete surgical removal of minimal and mild endometriosis improves outcome of subsequent IVF/ICSI treatment. Reprod Biomed Online. 2011; 23:389–395.

29. Gylfason JT, Kristjansson KA, Sverrisdottir G, Jonsdottir K, Rafnsson V, Geirsson RT. Pelvic endometriosis diagnosed in an entire nation over 20 years. Am J Epidemiol. 2010; 172:237–243.